论文部分内容阅读
The phase Ⅰ/Ⅱ studies and ongoing phase Ⅲ evaluate the influence of a proprietary extracts mixture of selected vegetables termed SV that contains known antitumor components on the survival benefit of stage Ⅲll-Non-small cell lung cancer (NSCLC) patients.